This Tarsus Pharmaceuticals Inc. (NASDAQ: TARS) report was produced by Stock Traders Daily. Over the past 20 years our metholdology has been refined to help identify strategies for both individual ...
Barclays analyst Balaji Prasad assigned a Buy rating to Tarsus Pharmaceuticals (TARS – Research Report) today and set a price target of ...
H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Tarsus Pharmaceuticals (TARS – Research Report) today and set a price ...
Zacks.com on MSN9d
Wall Street Analysts Believe Tarsus Pharmaceuticals (TARS) Could Rally 41.09%: Here's is How to TradeShares of Tarsus Pharmaceuticals, Inc. (TARS) have gained 22.4% over the past four weeks to close the last trading session at $44.83, but there could still be a solid upside left in the stock if short ...
The average of price targets set by Wall Street analysts indicates a potential upside of 41.1% in Tarsus Pharmaceuticals (TARS). While the effectiveness of this highly sought-after metric is ...
Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback